Company profile
Owlet, Inc.
NYSE: OWLT · Healthcare · Medical - Devices
#346 of 1,422 Healthcare companies by revenue73rd-percentile growth
EA Score
49DFH 56DQ 27GM 68SS 52
v0.1 · 65/100 weight · provisional
↑ Piotroski F, revenue growth (YoY) · ↓ disclosure history, listing tenure
Methodology →Revenue TTM
$107.1M
Rev growth YoY (TTM)
+26.8%
Net income (FY)
-$39.7M
Employees
111
as of 2026-08-18
Market cap
$104.5M
as of 2026-08-18
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$105.7M$105.7M2025
Net income-$39.7M-$39.7M2025
Operating income-$8.3M-$8.3M2025
Total assets$85.6M$85.6M2025
Liabilities$50.2M$50.2M2025
Equity$19.0M$19.0M2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY21
FY21
FY23
FY23
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Owlet, Inc.’s revenue?
Owlet, Inc. booked $105.7M in FY2025 revenue, growing 35% year over year — faster than most Healthcare companies we track, at a -37.5% net margin.
Peers · Healthcare
Theravance Biopharma Inc75B+Zevra Therapeutics, Inc.70BZymeworks Inc.55CPlanet 13 Holdings Inc.44DSanara MedTech Inc.61CSutro Biopharma, Inc.47DNeighbors
Utah →Key facts
CEOKurt Workman
SectorHealthcare
IndustryMedical - Devices
HeadquartersLehi, UT
ExchangeNYSE: OWLT
Employees111
IPO date2020-11-05
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.